Dr Aleksandar Danilovski is a seasoned pharmaceutical executive with almost 30 years’ professional experience. As founder and managing partner of DALISCO d.o.o. he supports several organisations in Europe and the United States as a Scientific Advisory Board member and sits, as non-executive director, on the Board of Directors for two further European companies.
Dr Danilovski’s previous positions include Chief Scientific Officer at Xellia Pharmaceuticals AS (Denmark), Vice President and Head of European R&D at Barr Laboratories Inc. (United States) and a Management Board member for PLIVA Pharmaceuticals d.d. (Croatia). He gained his PhD in Chemistry from the University of Zagreb, Croatia in collaboration with Cambridge University, UK.